about
p53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell linesDendritic Cells in Oncolytic Virus-Based Anti-Cancer TherapyOncolytic Replication of E1b-Deleted AdenovirusesMolecular imaging with bioluminescence and PET reveals viral oncolysis kinetics and tumor viability.Transarterial injection of H101 in combination with chemoembolization overcomes recurrent hepatocellular carcinoma.Gene therapy for cancer treatment: past, present and futureTherapeutic effects of a fusogenic newcastle disease virus in treating head and neck cancerVirotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter.Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.Cytolytic replication of echoviruses in colon cancer cell linesOncolytic vaccinia virus therapy of salivary gland carcinomaOncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells.Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice.Methods for gene transfer to the central nervous system.Replication-selective oncolytic viruses in the treatment of cancer.Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective studyOncolytic viruses for cancer therapy I. Cell-external factors: virus entry and receptor interaction.Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: a pilot phase II clinical trial.Replication-competent herpes simplex vectors: design and applications.Strategies to achieve systemic delivery of therapeutic cells and microbes to tumors.Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in miceCoxsackievirus B3 vaccines: use as an expression vector for prevention of myocarditis.Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagyEnhancing biological therapy through conditional regulation of protein stability.HSV Recombinant Vectors for Gene Therapy.Intralesional immunotherapy for melanoma.Virotherapy in cancerOncolytic viruses in head and neck cancer: a new ray of hope in the management protocol.Virotherapy of digestive tumors with rodent parvovirus: overview and perspectives.Investigation of cytotoxicity of negative control peptides versus bioactive peptides on skin cancer and normal cells: a comparative study.Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.Oncolytic immunotherapy: unlocking the potential of viruses to help target cancerDetection of free peritoneal cancer cells in gastric cancer using cancer-specific Newcastle disease virus.Oncolytic Viral Therapy for Mesothelioma.Newcastle disease virus mediates pancreatic tumor rejection via NK cell activation and prevents cancer relapse by prompting adaptive immunity.Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells.Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases.Multi-stability and multi-instability phenomena in a mathematical model of tumor-immune-virus interactions.In Vitro Synergistic Enhancement of Newcastle Disease Virus to 5-Fluorouracil Cytotoxicity against Tumor Cells.Oncolytic Virotherapy versus Cancer Stem Cells: A Review of Approaches and Mechanisms.
P2860
Q24672443-AF00FA68-3A0C-499C-8754-159A8DD9F030Q26774345-6DD02FED-A686-4BC5-BB60-F6D8C879C61AQ26777406-0E46650C-7800-4076-8B37-D32FB674C91FQ34099721-C0C55468-C154-4DE8-BA84-86ED9092F5A2Q34993726-52E04FD2-5026-43F2-AFED-63FB5898F7A4Q35040146-7598A9F9-20C6-444F-9F81-EA23788C2F77Q35050645-1C265658-9467-453C-8EA3-00D1716FFE0BQ35058583-AF0E28E4-579A-4992-8E48-FFECB03233AEQ35223458-8015C3A7-8AD4-4E94-A6CD-1E097187A0E6Q35541517-A5ECF9F3-109D-4745-8E6A-CB3541FE17E8Q35549696-E8540180-F1AF-40FB-869F-3FBA59998387Q35635226-907426D8-12D6-4131-BB05-C589B6DEC40DQ35811062-055F4E3E-BB70-4D41-A85A-A3B6822991ABQ35902332-7BD6E45A-3436-487A-B25C-5059B63B506BQ35912403-E74F0121-CFF3-4FC0-AEB4-6B0830BE6E7FQ36028552-9020E847-39FD-4955-9646-2ADED54FF26BQ36072752-1539F618-256D-497E-949E-2EEEBD567408Q36180392-75A5E264-B6D3-401B-93B4-795FEEE4FDF2Q36288909-E37D3320-57DD-40B6-9BA4-B3F784BF7314Q36675446-CAE9CBC0-A13B-429B-BEEB-F33E3CF1090DQ37132189-FAE25F14-3857-4007-B048-581D117FE619Q37340465-837B34AC-4392-4BA4-AB75-E528EA35E27EQ37644099-D71F2FCD-3B0D-41C2-8623-19BAF7565FEDQ37671855-CECBBA6F-8E48-4BF3-9DD3-3A4DD71CF0A4Q37787777-FDB883B7-B24A-437E-A118-07B9082F5B96Q38168460-10F03673-6657-4B13-AF98-C0B6D7E64908Q38253646-1D9F60F8-F917-4DAF-A449-A239DE62D436Q38264443-5E64488D-2E8F-4A90-80CD-D41E1C6E7C0FQ38726011-F363C0C7-12BE-4479-B90B-9ADE52F66F3AQ39292187-2EFAFE81-3CA4-4C7C-AF7D-80AF4E3FE743Q39315516-BF2202B0-CDF8-4AB1-8CAE-B8B653E3509EQ39437344-B87EB1FD-4CE2-4B0A-AFCB-EE44F1492850Q39776879-EFF8F336-C3EB-467F-8A00-9F206232D6DDQ40051845-4E732ED8-2D5C-4D1E-BA33-A2AA1A580DD9Q40063602-72786BD6-A1C2-414D-85C9-B4D71172BA09Q40461869-B6BCA6B8-9B52-41E8-8404-8ADE816C5FA8Q40566666-F1B14C20-62D9-4CD4-9027-949BBC050586Q45367535-7399F33A-1DDB-443A-8F30-1BCAC4BB2883Q50905634-DE7CA02E-83DE-45A1-9CEF-38749ED75C5FQ52718361-A11B6251-6905-4945-B603-7172EEDE4213
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Viral oncolysis.
@ast
Viral oncolysis.
@en
Viral oncolysis.
@nl
type
label
Viral oncolysis.
@ast
Viral oncolysis.
@en
Viral oncolysis.
@nl
prefLabel
Viral oncolysis.
@ast
Viral oncolysis.
@en
Viral oncolysis.
@nl
P1433
P1476
Viral oncolysis.
@en
P2093
John T Mullen
Kenneth K Tanabe
P304
P356
10.1634/THEONCOLOGIST.7-2-106
P577
2002-01-01T00:00:00Z